Financials
Financial year 2025
PHARMANEMA from Leuven, company number BE0479052415, closed financial year 2025 with a result of € 35,668 after tax. For that financial year PHARMANEMA recorded a gross margin of € 114,505 and equity of € 357,607. Compared with financial year 2024, the result moved from € 37,287 to € 35,668. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 357,607
▲ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 35,668
▼ 4% vs 2024
Profit after tax over the fiscal year.
€ 95,893
▼ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 10,000 paid out
28 % of the profit went to the shareholders, mostly to VANHALEWYCK-VAN OOSTERWYCK (100 % of the shares). That is where the money ends up.
People and assets in 2025
€ 4,698
▲ 130% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 454,518
▲ 21% vs 2024
€ 46,326 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 84,717
▲ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 81,260 | € 105,891 | € 99,131 | € 114,505 | ▲ 16% |
| Profit after taxes | € 49,634 | € 73,385 | € 37,287 | € 35,668 | ▼ 4% |
| Equity | € 281,267 | € 304,652 | € 331,940 | € 357,607 | ▲ 8% |
| Total debts | € 377,387 | € 436,831 | € 478,582 | € 552,413 | ▲ 15% |
| Cash | € 76,131 | € 273,337 | € 106,707 | € 95,893 | ▼ 10% |
| Land & buildings | € 192,020 | € 192,801 | € 455,798 | € 546,195 | ▲ 20% |
| Retained profit | € 256,267 | € 279,652 | € 306,940 | € 332,607 | ▲ 8% |
| Dividend | € 25,000 | € 50,000 | € 10,000 | € 10,000 | |
| Bank debt | € 135,753 | € 112,965 | € 375,599 | € 454,518 | ▲ 21% |
| Balance sheet total | € 658,655 | € 741,483 | € 810,521 | € 910,021 | ▲ 12% |
By gross margin, PHARMANEMA ranks 4th of 5 companies with main activity “Detailhandel in farmaceutische producten” in Leuven that publish figures (fiscal year 2025).
Key figures of PHARMANEMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMANEMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMANEMA?
What happened at PHARMANEMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 35,668 (▼ 4% vs 2024). Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 49,634 profit in 2022 to € 35,668 profit in 2025.
Paid € 31,701 in corporate taxes since 2022.
Best year ever: 2023, with € 73,385 profit.
Paid out € 95,000 in dividends to the owners in total.
Management
The stake of VANHALEWYCK-VAN OOSTERWYCK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMANEMABehind PHARMANEMA is Vanhalewyck-Van Oosterwyck BV. The shares are held by VANHALEWYCK-VAN OOSTERWYCK (100%).
Directors
According to the 2025 annual accounts
Director · represented by Tom Vanhalewyck
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Albert Woutersstraat 9
3012 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Leuven
Same main activity (Detailhandel in farmaceutische producten), 6 active companies in Leuven, largest first.
€ 303,869 gross margin · 2025
€ 272,349 gross margin · 2025
MANAGEMENT CAROLINE VANDECASTEELE
€ 168,100 gross margin · 2025
€ 64,957 gross margin · 2025
Details
- Company number
- 0479.052.415
- VAT number
- BE 0479.052.415
- Registered office
- Albert Woutersstraat 9, 3012 Leuven
- Names & denominations
- PHARMANEMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 2002
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers